Kamlesh Sahu

Dr. Kamlesh Sahu


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2014 in Theoretical Biology and Medical Modelling
Verified
Journal Article
Open access
PDF file
Jack TuszynskiJack Tuszynski
Jack Tuszynski
PWPhilip Winter
Philip Winter
DWDiana White
Diana White
CTChih-Yuan Tseng
Chih-Yuan Tseng
KSKamlesh Sahu
Kamlesh Sahu
RERabab M Abou El-Magd
Rabab M Abou El-Magd
A variety of topics are reviewed in the area of mathematical and computational modeling in biology, covering the range of scales from populations of organisms to electrons in atoms. The use of maximum entropy as an inference tool in the fields of biology and drug discovery is discussed. Mathematical and computational methods and models in the areas of epidemiology, cell physiology and cancer are surveyed. The technique of molecular dynamics is covered, with special attention to force fields for protein simulations and methods for the calculation of solvation free energies. The utility of quantum mechanical methods in biophysical and biochemical modeling is explored. The field of computational enzymology is examined.

23 October 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
AKAlicja Kuban-Jankowska
Alicja Kuban-Jankowska
MAGDALENA GORSKA-PONIKOWSKAMAGDALENA GORSKA-PONIKOWSKA
MAGDALENA GORSKA-PONIKOWSKA
KSKamlesh Sahu
Kamlesh Sahu
TKTomasz Kostrzewa
Tomasz Kostrzewa
Michał WoźniakMichał Woźniak
Michał Woźniak
Jack TuszynskiJack Tuszynski
Jack Tuszynski
Background: Docosahexaenoic acid (DHA) is an essential polyunsaturated fatty acid compound present in deep water fishes and dietary supplements, with a wide spectrum of potential health benefits, ranging from neurological to anti-inflammatory. Methods: Due to the fact that DHA is considered a breast cancer risk reducer, we examined the impact of DHA on MCF-7 breast cancer cells’ viability and its inhibitory properties on protein tyrosine phosphatase 1B (PTP1B), a pro-oncogenic phosphatase. Results: We found that DHA is able to lower both the enzymatic activity of PTP1B phosphatase and the viability of MCF-7 breast cancer cells. We showed that unsaturated DHA possesses a significantly higher inhibitory activity toward PTP1B in comparison to similar fatty acids. We also performed a computational analysis of DHA binding to PTP1B and discovered that it is able to bind to an allosteric binding site. Conclusions: Utilizing both a recombinant enzyme and cellular models, we demonstrated that DHA can be considered a potential pharmacological agent for the prevention of breast cancer.